CMP:
Rs. 1248.15; Buy at current levels.
Short term Target – Rs. 1350; STOP LOSS
– Rs. 1148.29; Market Cap: Rs. 16,973.94 Cr; 52 Week High/Low: Rs. 1579.90 / Rs. 1190.00
Total
Shares: 13,59,92,817 shares; Promoters : 6,93,56,336 shares –51.00 %; Total Public
holding : 6,66,36,481 shares – 49.00 %; Book
Value: Rs. 36.00; Face Value: Rs. 1.00; EPS: Rs. 38.90; Div: 2800.00 % ; P/E: 32.08 times; Ind. P/E: 39.12;
EV/EBITDA: 24.38.
Total
Debt: ZERO; Enterprise Value:
Rs. 16,679.14 Cr.
EX - DIVIDEND on 6th NOV 2013 - Rs. 9.00 (900%)
COLGATE PALMOLIVE (INDIA) LTD: The Company was founded on 23 September, 1937 and is based in
Mumbai, India. The company is the subsidiary of Colgate Palmolive Company of
USA. The company offered
11,79,000 equity shares of Rs. 10 each at a premium of Rs. 15.00 to the general
public in November, 1978. Colgate-Palmolive (India) Limited provides oral
care products. The company offers products that include toothpastes,
toothpowder and toothbrushes under the 'Colgate' brand, as well as a
specialized range of dental therapies under the banner of Colgate Oral
Pharmaceuticals. The company also provides a range of personal care products
under the brand name 'Palmolive'. The oral care product mix includes:
Toothpastes which comprises of Colgate Dental Cream, Colgate Total 12, Colgate
Kids Tooth Paste, Colgate Fresh Energy Gel, Colgate Herbal, Colgate Herbal
White, and Colgate Cibaca Top. Its Tooth Brushes products comprises of Colgate
Kids, Colgate Navigator Plus, and Colgate Sensitive, Colgate Extra-Clean,
Colgate Super 55, Colgate Cibaca Top, Colgate Motion, Colgate Massager, Colgate
Super Junior Flexible, and Colgate Super Child Flexible. Other products offered
by the company include tooth powder and whitening products. Its Personal care
product mix includes: Shower gel which comprises of Palmolive Aroma Shower Gel
– Sensual, Palmolive Aroma Shower Gel – Relax, and Palmolive Aroma Shower Gel –
Revive. It’s Bar soaps products comprise of Palmolive Aroma Soap – Revive and
Palmolive Aroma Soap – Relax. Company’s Liquid hand wash products comprise of
Palmolive Aroma Liquid Hand Wash – Revive and Palmolive Aroma Liquid Hand Wash
– Relax. Colgate’s Talcum Powder products comprises of Palmolive Aroma Talcum
Powder - Revive and Palmolive Aroma Talcum Powder – Relax. Other products in
the personal care includes Palmolive shave cream and Palmolive Charmis cream.
House hold care products include Axion Dish Washing paste. Colgate’s from the
Dentist to the company offers Dentist product mix that includes Gingivitis
treatment comprising of PerioGard and Total Plax, Sensitivity treatment
products comprising of Gel Kam and Sensitive, Tooth whitening products,
Fluoride therapy consists of Phos-Flur anti-cavity fluoride rinse and lastly Mouth
ulcer treatment which consists of Oragard-B. Colgate Palmolive (India) Ltd is locally
compared with Amar Remedies Ltd, Farmax India Ltd, Gillette India Ltd, Godrej
Consumer Products Ltd, Hindustan Unilever, JHS Svendgaard Laboratories Ltd,
Jyothy Laboratories, Nirma Ltd, Procter & Gamble Ltd and Globally with Beiersdorf AG of Germany,
Reckitt Benckiser PLC of UK, Kimberly-Clark Corporation of USA, Church &
Dwight Co., Inc of USA, Clorox Company of USA, Paos Holdings Berhad of
Malaysia, Niitaka Co ltd of Japan.
Investment Rationale:
India’s oral care market is around $100 Cr and is expected to
grow at a CAGR of about 14 % during 2011–2015, which is much higher than the
global growth rate. This has led to an increase in the number of oral care
companies entering the space, thereby stiffening the competition. P&G has
made a similar move by launching its first toothpaste in the country under the
Oral-B brand, which commands close to 30 % share in the toothbrush market.
Although P&G’s Oral-B has a strong brand recall in India, Colgate-Palmolive
has also positioned itself well to defend its market share here. In India only
42 % of the people living in Indian villages and small towns use toothpaste,
the proportion is expected to increase with rising rural income and greater
awareness about oral hygiene through advertisements, dental camps and free
dental checkups. Colgate has done well in this regard by building strong
distribution strength across rural India. Colgate now has the highest reach
among all consumer products companies in the country. More than 30 %
of India’s population suffers from gum sensitivity and oral hygiene problems.
Thus, India’s urban population is continuously upgrading from regular
toothpastes to dental creams due to which this category is growing at 30 %–40 %
annually. Colgate has launched its innovative products such as Colgate Total
Pro Gum Health and Colgate Sensitive which will help Colgate to compete with
P&G’s Oral-B Pro-Health. Colgate launched several products and a new
production facility in India. To support its products in the wake of rising
competition, the company also increased its advertising spending which
increased by 31
% during the first half of 2013. This has resulted in market share gains in
toothpastes, which has grown from 52 % in 2012 to 56 % presently. Company’s annual Report 2013 emphasizes the importance of
innovations, market development and distribution expansion to drive growth in
oral care business. Colgate is driving market development through consumer
awareness program like ‘Brush at Night’, ‘Oral Health Month’ and ‘Bright
Smiles, Bright Future’. Innovations are creating new segments like Gum Care, Sensitivity
& Visible White. Colgate has launched Colgate Total Pro Gum Health and
Colgate Visible White toothpaste in FY13. It has also launched Colgate MaxFresh
and Colgate 360 (battery operated) in toothbrush category. Strong efforts on distribution
are underway; wherein store coverage increased 40% and rural coverage increased
by 25% in FY13. Given that P&G’s toothpaste launch was in the
pipeline for some time, competitors have been gearing up for this, and this gets evidenced
by a spate of promotions and price-offs, it is expected that Colgate’s
ad-spends will too increase. Colgates has a very strong leadership in toothpaste
category, it has strengthened its leadership position in toothpaste category
from 52.9 % in FY12 to 54.6% in FY13, while market share in toothbrush
strengthened to 40.5 %. Hindustan Unilever and Dabur India are at risk of market
share loss wherein, the toothpastes contributes 6 % - 7 % of Hindustan Unilever’s
and 9 % - 10 % of Dabur India’s revenues. Colgate management is committed for continued
investments in India and their efforts are underway for toothpaste facility in
Sanand, Gujarat and toothbrush facility in Sricity, Andhra Pradesh. The company
has already expended capex of Rs. 1oo Cr and capital advance of Rs. 54.80 Cr
and expects commercial production in FY14.
Outlook and
Valuation:
Colgate has been present in India for more than 76 years.
With products across all oral care categories and price points, it is one of
the most popular and preferred oral hygiene brands in the country. Compared to
P&G, Colgate offers a much larger assortment of oral care products in a
wide price range. This allows consumers to trade up and down gradually
depending on macroeconomic conditions without impacting Colgate’s sales volume.
Colgate-Palmolive was faced with a similar situation in Brazil where it
commands over 70 % market share. When P&G entered the country’s oral care
market in 2009, a majority of its market share gains came from smaller
competitors and overall category growth for Colgate continued due to maintained strong brand equity among consumers. P&G’s
market share gains in India will also come from smaller competitors such as HUL
and Dabur given that Brazil and India are quite similar in terms of economic
growth and where Colgate-Palmolive has a dominating presence. Recently, Colgate transferred the GSSO division to Colgate Global Business
Services Pvt Ltd (CGBSPL) which will enable Colgate Palmolive India to focus on
its core business. Colgate divested GSSO by way of slump sale to CGBSPL for a
consideration of Rs. 59.89 Cr. With this transfer, expenses and income
resulting from this entity would no more reflect in Colgate’s financials w.e.f
April 2013. On performance side the volume
growth in
toothpaste category has moderated from 13 % in recent past to 10 % in FY13.
Though, no qualitative input is available in the annual report, but with market checks seems to indicate slower growth in value tiers. Media spends has risen from Rs. 260
Cr in FY12 to Rs. 350 Cr in FY13, A&P spend increased from 15.7 % in FY12
to 15.9% in FY13. This probably hints at preparedness of Colgate for upcoming
entry of P&G in India. The management exuberated confidence that the Oral Care
category would continue to grow at a healthy pace given the size of the
opportunity, but also cited that competition may intensify in near future. With
the underlying volume growth of 10 % - 11 % is in sync with management
commentary. However, launch of P&G in India, should drive promotions in this category. Colgate Palmolive India has increased media spends in FY13; higher promotion
spends in FY14E should be underway. There is overhang on earnings in the short-run.
The company has a Cash flow generation of Rs. 460 Cr in FY13 as against Rs. 300
Cr in FY12; also the company has a strong dividend payout at 77 % vs average of
72 % in last 3 years. Higher dividend payout exuberates confidence on future
cash generation. At the current market price of Rs. 1239.95,
the stock is trading at a PE of 29.86 x FY13E and 25.78 x FY14E respectively. The
company can post Earning per share (EPS) of Rs. 41.80 for FY13E and Rs. 48.40 for FY14E. It is expected that with the company’s surplus scenario is likely to
continue for the next three years & will keep its growth story intact for
the coming quarters also. One can ‘BUY’ in COLGATE PALMOLIVE INDIA LTD with a
target price of Rs. 1350.00 for shorter term and for Rs. 1430.00 for Medium to Long term investment.
KEY FINANCIALS | FY12 | FY13 | FY14E | FY15E |
SALES (Rs. Crs) | 2,623.80 | 3,084.10 | 3,514.70 | 4,083.60 |
NET PROFIT (Rs. Crs) | 446.50 | 496.80 | 567.90 | 658.10 |
EPS (Rs.) | 32.80 | 36.50 | 41.80 | 48.40 |
PE (x) | 43.20 | 38.80 | 34.00 | 29.30 |
P/BV (x) | 44.30 | 39.40 | 34.90 | 30.80 |
EV/EBITDA (x) | 36.90 | 32.40 | 25.20 | 21.00 |
ROE (%) | 109.00 | 107.40 | 109.00 | 111.7 |
ROCE (%) | 149.20 | 148.90 | 154.50 | 160.20 |
I would buy COLGATE PALMOLIVE (INDIA) LTD with a price target of Rs. 1,430 for the 6 month target. As I always say, I am a long term believer in markets & I do respect the markets and will keep a strict stop loss of 8 % or Rs. 1148.29 on your every purchase.
READ HERE TO KNOW MORE ON LONG TERM INVESTING - CLICK HERE
VIEW THE POWER POINT PRESENTATION ON